Stock TARO PHARMACEUTICAL INDUSTRIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Taro Pharmaceutical Industries Ltd. Other OTC

Equities

IL0010827181

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Taro Pharmaceutical Industries Ltd.
06-25 Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index CI
06-24 Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Taro Pharmaceutical Industries : Sun Pharma Completes Taro Merger Form 6 K
PU
Taro Shareholders Approve Merger with Sun Pharma
PR
Taro Shareholders Approve Merger with Sun Pharma
AQ
Taro Pharmaceutical Industries : Shareholders Approve Merger with Sun Pharma - Form 6-K
PU
Taro Pharmaceutical Industries : PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024 - Form 6-K
PU
Taro: Fiscal Q4 Earnings Snapshot
AQ
Taro Provides Results for Year Ended March 31, 2024
BU
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.
PR
Taro to Release Full Year Results on May 20, 2024
BU
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger
AQ
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
BU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS
PR
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
BU
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
BU
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
BU
Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm
PR
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
PR
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ANSS, TARO, MDC
PR
Taro: Fiscal Q3 Earnings Snapshot
AQ
Taro Provides Results for December 31, 2023
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TARO Stock
  4. Stock
  5. News Taro Pharmaceutical Industries Ltd.
  6. Press Releases